What is the pathophysiology of Cavernous Sinus Thrombosis (CST) with Streptococcus pneumoniae (S. pneumoniae) meningitis in an adult or elderly patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Cavernous Sinus Thrombosis with Streptococcus pneumoniae Meningitis

Cavernous sinus thrombosis (CST) with S. pneumoniae meningitis develops through direct extension of infection from adjacent paranasal sinuses (primarily sphenoid and ethmoid) or via hematogenous spread during bacteremic meningitis, resulting in septic thrombophlebitis of the cavernous sinus with subsequent venous obstruction and cranial nerve compression.

Primary Infection Source and Spread Mechanisms

The pathophysiologic cascade begins with S. pneumoniae infection establishing itself in the paranasal sinuses or meninges, with two distinct mechanisms of cavernous sinus involvement 1, 2:

  • Direct anatomic extension: Sphenoid sinusitis spreads directly to the adjacent cavernous sinus through the thin bony walls separating these structures 2
  • Hematogenous seeding: During pneumococcal bacteremia and meningitis, bacteria seed the cavernous sinus via bloodstream dissemination 3
  • Retrograde venous spread: Infection propagates through valveless facial venous plexus connecting facial structures to the cavernous sinus 2

Thrombosis Formation

The septic process triggers endothelial damage and activation of the coagulation cascade within the cavernous sinus 1, 4:

  • Bacterial invasion causes direct endothelial injury and inflammatory cytokine release
  • Inflammatory mediators activate tissue factor and platelet aggregation
  • Progressive thrombosis obstructs venous drainage from orbital structures 4
  • Thrombus propagation can extend to contralateral cavernous sinus through intercavernous connections 2

Cranial Nerve Involvement

Cranial nerves III, IV, V (ophthalmic and maxillary divisions), and VI traverse the cavernous sinus and become compressed or directly infected 4:

  • CN VI is most vulnerable due to its location freely within the sinus (not protected by dural sheath), causing lateral rectus palsy as the earliest sign 4
  • CNs III and IV run in the lateral wall and are affected as thrombosis progresses 4
  • CN V involvement produces facial pain and sensory deficits 4

Venous Obstruction Consequences

Impaired venous drainage produces characteristic orbital manifestations 1, 4:

  • Chemosis and periorbital edema from venous congestion
  • Proptosis from increased orbital venous pressure
  • Retinal venous engorgement and potential vision loss
  • Elevated intraocular pressure

Meningeal Extension

In cases with concurrent S. pneumoniae meningitis, the pathophysiology involves 5, 6:

  • Direct spread through dural venous sinuses to subarachnoid space
  • Hematogenous seeding during bacteremia
  • Inflammatory CSF findings with elevated protein, decreased glucose, and pleocytosis 6
  • Potential for increased intracranial pressure from combined venous obstruction and meningeal inflammation 5

Systemic Complications

The septic thrombophlebitic process can extend beyond the cavernous sinus 4:

  • Septic emboli to pulmonary circulation
  • Extension to other dural venous sinuses (superior sagittal, transverse)
  • Cerebral venous infarction from progressive thrombosis 5
  • Subdural empyema or brain abscess formation 5

Critical Pathophysiologic Distinction

A crucial caveat: While S. aureus is the most common pathogen in CST overall 1, 4, 3, S. pneumoniae CST typically occurs in the context of pneumococcal meningitis or severe sinusitis 5, 6. The viridans streptococci group (including S. constellatus) has been documented in CST from sinus sources 6, but S. pneumoniae specifically represents hematogenous spread during invasive pneumococcal disease rather than primary sinus infection 5.

References

Research

Septic cavernous sinus thrombosis: A review.

Survey of ophthalmology, 2021

Research

High risk and low prevalence diseases: Cavernous sinus thrombosis.

The American journal of emergency medicine, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Septic cavernous sinus thrombosis due to Streptococcus constellatus infection.

Journal of the Formosan Medical Association = Taiwan yi zhi, 2003

Related Questions

What is the diagnosis and treatment for cavernous sinus thrombosis (CST)?
What is the treatment for cavernous sinus thrombosis?
What are the signs of cavernous sinus thrombosis?
What are the risks and management strategies for a patient with suspected cavernous sinus thrombosis, particularly with a history of recent sinus infection or trauma?
What are the symptoms of cavernous sinus thrombosis?
How do I differentiate between acute decompensated heart failure and pneumonia in a patient presenting with hypotension, tachycardia, rales, no edema, urinary retention, and tachypnea?
Is it safe to start IV ciprofloxacin and IV cefotaxime for a diabetic patient with osteomyelitis caused by Staphylococcus haemolyticus and Klebsiella pneumoniae, given the specific antibiotic sensitivities?
What is the recommended starting dose for an elderly patient with treatment-resistant depression or bipolar depression for the olanzapine (atypical antipsychotic) and fluoxetine (selective serotonin reuptake inhibitor) combination?
What alternative ICD-10 (International Classification of Diseases, 10th Revision) codes can be used for a patient with advancing dementia, as F03.90 is not a covered diagnosis?
What are the recommended treatment options for an adult patient with a higher Body Mass Index (BMI) and comorbidities such as hypertension and diabetes who is experiencing loud snoring?
What is the neurosurgery management approach for a patient with Cavernous Sinus Thrombosis (CST) and Streptococcus pneumoniae (S. pneumoniae) meningitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.